4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0000904454-16-001393
CIK 0001105533operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:07 PM ET
Size
7.2 KB
Accession
0000904454-16-001393
Insider Transaction Report
Form 4
Pharmstandard International S.A.
10% Owner
Transactions
- Purchase
Common Stock
2016-08-24$4.57/sh+55,224$252,374→ 13,009,089 total(indirect: See footnote)
Public Joint Stock Co Pharmstandard
10% Owner
Transactions
- Purchase
Common Stock
2016-08-24$4.57/sh+55,224$252,374→ 13,009,089 total(indirect: See footnote)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.55 to $4.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:07 PM ET
- Size
- 7.2 KB